Lung Immune Therapy Evaluation (LITE) Risk, a Novel Prognostic Model for Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Blockade
Titel:
Lung Immune Therapy Evaluation (LITE) Risk, a Novel Prognostic Model for Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Blockade
Auteur:
Navani, Vishal Meyers, Daniel E. Ruan, Yibing Boyne, Devon J. O'Sullivan, Dylan E. Dolter, Samantha Grosjean, Heidi AI Stukalin, Igor Heng, Daniel Y.C. Morris, Don G. Brenner, Darren R. Sangha, Randeep Cheung, Winson Y. Pabani, Aliyah